[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2488407T3 - Preparación farmacéutica que contiene lipasa de origen bacteriano - Google Patents

Preparación farmacéutica que contiene lipasa de origen bacteriano Download PDF

Info

Publication number
ES2488407T3
ES2488407T3 ES09776346.0T ES09776346T ES2488407T3 ES 2488407 T3 ES2488407 T3 ES 2488407T3 ES 09776346 T ES09776346 T ES 09776346T ES 2488407 T3 ES2488407 T3 ES 2488407T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
preparation containing
bacterial origin
containing lipase
lipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09776346.0T
Other languages
English (en)
Inventor
Manfred KURFÜRST
Rainer Friedel
Olaf Friedrich
Silke HÜTTLER
Christian RÄMSCH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordmark Arzneimittel GmbH and Co KG
Original Assignee
Nordmark Arzneimittel GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Arzneimittel GmbH and Co KG filed Critical Nordmark Arzneimittel GmbH and Co KG
Application granted granted Critical
Publication of ES2488407T3 publication Critical patent/ES2488407T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Preparación farmacéutica, que comprende lipasa bacteriana en solución acuosa para el tratamiento de trastornos digestivos.

Description

imagen1
imagen2
imagen3

Claims (1)

  1. imagen1
ES09776346.0T 2009-01-29 2009-01-29 Preparación farmacéutica que contiene lipasa de origen bacteriano Active ES2488407T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/000566 WO2010085975A1 (de) 2009-01-29 2009-01-29 Pharmazeutisches präparat enthaltend lipase bakteriellen ursprungs

Publications (1)

Publication Number Publication Date
ES2488407T3 true ES2488407T3 (es) 2014-08-27

Family

ID=41091375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09776346.0T Active ES2488407T3 (es) 2009-01-29 2009-01-29 Preparación farmacéutica que contiene lipasa de origen bacteriano

Country Status (13)

Country Link
US (2) US20110293590A1 (es)
EP (2) EP2786761A1 (es)
JP (1) JP5970189B2 (es)
CN (1) CN102231988A (es)
BR (1) BRPI0922653B8 (es)
CY (1) CY1115519T1 (es)
DK (1) DK2391382T3 (es)
ES (1) ES2488407T3 (es)
HR (1) HRP20140715T1 (es)
PL (1) PL2391382T3 (es)
PT (1) PT2391382E (es)
SI (1) SI2391382T1 (es)
WO (1) WO2010085975A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
EP2295039B2 (de) 2009-08-28 2022-10-26 Nordmark Pharma GmbH Verfahren zur Herstellung von Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und hiernach hergestellte Pankreatin-Pellets
PL2489349T3 (pl) 2011-02-17 2014-09-30 Nordmark Arzneimittel Gmbh & Co Kg Granulki pankreatynowe, zwłaszcza mikrogranulki pankreatynowe, oraz sposób ich produkcji
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
WO2013146529A1 (ja) * 2012-03-28 2013-10-03 不二製油株式会社 ランダムエステル交換油脂の製造方法
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
DE102017104480A1 (de) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Wässrige Lösung von Burlulipase umfassend Kalziumionen
DE102017104482A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung umfassend Pankreatin und einen lipasehaltigen Überzug
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
DE102017104501A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung umfassend einen Träger und einen Überzug enthaltend wenigstens eine Lipase
MX2022002473A (es) 2019-08-30 2022-08-02 Codexis Inc Variantes de lipasa modificadas geneticamente.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2189948A (en) 1938-10-31 1940-02-13 Griffith Laboratories Sterilization of pancreatin
DE2923279C2 (de) 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
US5063160A (en) * 1989-03-16 1991-11-05 Olin Corporation Identification, characterization, and method of production of a novel microbial lipase
JP3025528B2 (ja) 1989-11-24 2000-03-27 ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング パンクレアチン製剤
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
CA2110497C (en) * 1991-07-01 2005-04-19 Reinhard Braatz Use of bacterial lipases for producing drugs for maldigestion therapy
DE4227385A1 (de) 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US6270723B1 (en) 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
EP1272044B1 (en) 2000-04-06 2004-08-11 The Hannah Research Institute Protein stabilised emulsions
AT502588B1 (de) * 2002-11-26 2010-05-15 Brenner Franz Papaya-mus
EP1486415A1 (en) 2003-06-12 2004-12-15 SSP Technology A/S Wind turbine blade and method of manufacturing a blade root
US6908789B1 (en) 2003-12-15 2005-06-21 Intel Corporation Method of making a microelectronic assembly
ATE407693T1 (de) * 2004-03-22 2008-09-15 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin,mit tensiden
DE602005022471D1 (de) * 2004-10-14 2010-09-02 Altus Pharmaceuticals Inc Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz
DE102004056340B4 (de) 2004-11-22 2010-11-18 Repower Systems Ag Vorrichtung und Verfahren zur Montage und/oder Demontage eines Bauteils einer Windkraftanlage
DE102005014868A1 (de) 2005-03-30 2006-10-05 Repower Systems Ag Offshore-Windenergieanlage mit rutschfesten Füßen
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
DE102006021982C5 (de) 2006-05-10 2010-10-07 Repower Systems Ag Gestaffelt abschaltbarer Windpark
CL2008000517A1 (es) * 2007-02-20 2008-08-08 Eurand Pharmaceuticals Ltd Composicion que comprende al menos una enzima digestiva; forma farmaceutica que la comprende; envase que comprende un recipiente sellado; metodo para tratar o prevenir un desorden asociado con deficiencia en la enzima digestiva.
DE102007014863A1 (de) 2007-03-26 2008-10-02 Repower Systems Ag Verfahren zum Betreiben einer Windenergieanlage
WO2008127567A1 (en) * 2007-04-13 2008-10-23 Beth Israel Deaconess Medical Center, Inc. Novel nutritional food products for improved digestion and intestinal absorption
DE102008012664A1 (de) 2008-01-30 2009-08-06 Repower Systems Ag Windenergieanlage und ein Turm oder Turmsegment und eine Türzarge dafür
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
EP2295039B2 (de) 2009-08-28 2022-10-26 Nordmark Pharma GmbH Verfahren zur Herstellung von Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und hiernach hergestellte Pankreatin-Pellets
PL2489349T3 (pl) 2011-02-17 2014-09-30 Nordmark Arzneimittel Gmbh & Co Kg Granulki pankreatynowe, zwłaszcza mikrogranulki pankreatynowe, oraz sposób ich produkcji

Also Published As

Publication number Publication date
EP2391382A1 (de) 2011-12-07
CN102231988A (zh) 2011-11-02
PL2391382T3 (pl) 2014-11-28
PT2391382E (pt) 2014-08-22
BRPI0922653B8 (pt) 2021-05-25
HRP20140715T1 (hr) 2014-09-26
JP5970189B2 (ja) 2016-08-17
EP2786761A1 (de) 2014-10-08
SI2391382T1 (sl) 2014-10-30
US20160287679A1 (en) 2016-10-06
WO2010085975A1 (de) 2010-08-05
DK2391382T3 (da) 2014-08-25
JP2012516289A (ja) 2012-07-19
US20110293590A1 (en) 2011-12-01
US10596235B2 (en) 2020-03-24
BRPI0922653B1 (pt) 2021-04-13
BRPI0922653A2 (pt) 2016-01-05
CY1115519T1 (el) 2017-01-04
EP2391382B1 (de) 2014-06-04

Similar Documents

Publication Publication Date Title
ES2488407T3 (es) Preparación farmacéutica que contiene lipasa de origen bacteriano
ES2512141T3 (es) Análogo peptídico de oxintomodulina
ES2486675T3 (es) Análogo de péptido de oxintomodulina
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
AR114143A2 (es) Formulaciones de comprimidos revestidos
BRPI1007658A2 (pt) sistema de travesseiro ativo para manipular as condições de repouso de uma pessoa e método para manipular condições de repouso de uma pessoa
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
NI201200038A (es) Conjugados de niacina y ácidos grasos y sus usos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CL2012003722A1 (es) Compuestos derivados del acido naf-2-ilacetico; composicion farmaceutica; y uso para el tratamiento del sida.
AR079160A1 (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
BR112012004377A2 (pt) terapia de reposição enzimática com progressão de dose para tratamento de deficiência de esfingomielinase ácida.
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
EA201791850A1 (ru) Борсодержащие малые молекулы
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
GT200600463A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
ES2531516T3 (es) Uso de escina
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
AR082943A1 (es) Formula nutricional predigerida
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
ES2508165T3 (es) Lactoferrina y sustancia blanca
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CL2012003006A1 (es) Compuestos derivados de lactonas esteroideas insaturadas en la posicion 7(8) y sus sales y estereoisomeros farmaceuticamente aceptables; composicion farmaceutica que las comprende; y su uso para el tratamiento del cancer.